Table 7 The clinical characteristics of patients in the two risk groups in TCGA-UM cohort (n = 80)
Clinical characteristics | Low-risk group (n = 31) | High-risk group (n = 49) |
|---|---|---|
Gender | ||
Male | 18 (51.4) | 27 (55.1) |
Female | 13 (48.6) | 22 (44.9) |
T staging | ||
T2 | 8 (25.8) | 6 (12.3) |
T3 | 14 (45.2) | 18 (36.7) |
T4 | 9 (29.0) | 25 (51.0) |
M staging | ||
M0 | 21 (67.7) | 30 (61.2) |
M1 | - | 4 (8.2) |
Unknown | 10 (32.3) | 15 (30.6) |
N staging | ||
N0 | 21 (67.7) | 31 (63.3) |
Unknown | 10 (32.3) | 18 (36.7) |
TMN stages | ||
II | 20 (64.5) | 19 (38.8) |
III | 11 (35.5) | 25 (51.0) |
IV | - | 4 (8.2) |
Unknown | - | 1 (2.0) |